Karyopharm Therapeutics Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Great. Thank you. Good morning, everyone. Welcome to Barclays Global Healthcare Conference. My name is Peter Lawson. I'm one of the biotech equity analysts at Barclays. I just want to thank everyone for taking the time out of the day. I've got a series of questions, but do ping me by e-mail, so it's [email protected] or ping me on Bloomberg.
It gives me a great pleasure to introduce the management team from Karyopharm today. I've got Michael Kauffman and various other members of management team as well on the line.
Questions & Answers
And so maybe it's just an opening question as kind of a 2- to 3-minute kind of overview kind of the company's differentiation in the oncology space, what would you kind of define as Karyopharm's core competencies?
Yes. Well
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
